4595 — Mizuho Medy Co Share Price
0.000.00%
Last trade - 00:00- ¥32bn
- ¥22bn
- ¥11bn
- 86
- 72
- 80
- 96
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 4.22% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.06 | ||
| Price to Tang. Book | 2.06 | ||
| Price to Free Cashflow | 8.66 | ||
| Price to Sales | 2.93 | ||
| EV to EBITDA | 4.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 30.91% | ||
| Return on Equity | 25.2% | ||
| Operating Margin | 46.88% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 6,427.6 | 4,205.45 | 13,137.32 | 17,581.83 | 10,989.74 | n/a | n/a | 11.34% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -10.49 | -63.08 | +1443.77 | +65.74 | -51.85 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
Directors
- Fuminari Karakawa CHM (73)
- Masashi Imamura MDR (62)
- Toshio Kambara DSL (57)
- Hiroshi Sasaki OTH (59)
- Kazuhiro Ichimaru OTH (61)
- Kenji Narahara OTH (58)
- Shinichi Akiyama IND (76)
- Katsumi Sasaki IND (76)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 2nd, 1977
- Public Since
- December 17th, 2015
- No. of Shareholders
- 8,549
- No. of Employees
- 180
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 9,524,397
- Address
- 5-4, Fujinoki-machi, TOSU-SHI, 841-0048
- Web
- https://www.mizuho-m.co.jp/
- Phone
- +81 942850303
- Auditors
- Deloitte Touche Tohmatsu LLC
Upcoming Events for 4595
Dividend For 4595.T - 80.0000 JPY
Similar to 4595
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the Mizuho Medy Co share price?
As of Today at 19:14 UTC, shares in Mizuho Medy Co are trading at ¥3,385. This share price information is delayed by 15 minutes.
How has the Mizuho Medy Co share price performed this year?
Shares in Mizuho Medy Co last closed at ¥3,385 and the price had moved by +50.31% over the past 365 days. In terms of relative price strength the Mizuho Medy Co share price has outperformed the Nikkei 225 Index by +7.3% over the past year.
What are the analyst and broker recommendations for Mizuho Medy Co?
The overall consensus recommendation for Mizuho Medy Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Mizuho Medy Co dividend yield?
The Mizuho Medy Co dividend yield is 3.55% based on the trailing twelve month period.
Does Mizuho Medy Co pay a dividend?
Last year, Mizuho Medy Co paid a total dividend of ¥120, and it currently has a trailing dividend yield of 3.55%.Looking ahead, shares in Mizuho Medy Co are due to go ex-dividend on 2024-06-27 and the next dividend pay date is 2024-09-01.
When does Mizuho Medy Co next pay dividends?
Mizuho Medy Co are due to go ex-dividend on 2024-06-27 and the next dividend pay date is 2024-09-01. The historic dividend yield on Mizuho Medy Co shares is currently 3.55%.
How do I buy Mizuho Medy Co shares?
To buy shares in Mizuho Medy Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Mizuho Medy Co?
As of the previous close price of ¥3,385, shares in Mizuho Medy Co had a market capitalisation of ¥32bn.
Where are Mizuho Medy Co shares listed?
Here are the trading details for Mizuho Medy Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4595
What kind of share is Mizuho Medy Co?
Based on an overall assessment of its quality, value and momentum Mizuho Medy Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Mizuho Medy Co share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Mizuho Medy Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mizuho Medy Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -6.31%.
As of the last closing price of ¥3,385, shares in Mizuho Medy Co were trading +11.82% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Mizuho Medy Co PE Ratio?
The Mizuho Medy Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥3,385.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Mizuho Medy Co?
Mizuho Medy Co's management team is headed by:
- Fuminari Karakawa - CHM
- Masashi Imamura - MDR
- Toshio Kambara - DSL
- Hiroshi Sasaki - OTH
- Kazuhiro Ichimaru - OTH
- Kenji Narahara - OTH
- Shinichi Akiyama - IND
- Katsumi Sasaki - IND